Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Israeli seed breeding start-up business Equinom has closed its Series B round of $10 million of funding.
Contract research company Eurofins Agroscience Services (EAS) has established its third field station in Parana state, Brazil.
French contract research company Staphyt (Inchy-en-Artois) has received GEP certification in Morocco.
Swiss inspection, verification, testing and certification company SGS has launched a soil microbiological analysis service, employing microbial biomass and soil respiration indicators.
US biopesticide company Marrone Bio Innovations (MBI - Davis, California) says that switching to its products from conventional chemical pesticides would, on average, result in net reductions of greenhouse gas emissions of 69-91% or 39-46 kg of carbon dioxide equivalents per acre per year.
Corteva Agriscience will phase out the production of the insecticide, chlorpyrifos, this year.
Corteva Agriscience is to ramp up production of its genetically modified herbicide-tolerant Enlist E3 soybeans for US and Canadian growers over the next five years.
Dutch bioproducts company Koppert Biological Systems and research partners are to open the São Paulo Advanced Research Centre for Biological Control (SPARCBio) next month.
Chinese company Lier Chemical has halted production at its glufosinate herbicide manufacturing plant in Guang’an in the Sichuan province.
The US-based, UK-listed bioproducts company, Plant Health Care (PHC – Raleigh, North Carolina) has been issued with its first US patent for its PREtec (plant elicitor response) peptide technology.
Syngenta has "relaunched" the NK seed brand in Latin America.
BASF is building a new regional production hub in Singapore for its Agricultural Solutions business in the Asia Pacific region.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.